MetLife Investment Management, LLC - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$198,332
-11.7%
11,0430.0%0.00%0.0%
Q2 2023$224,615
-6.5%
11,0430.0%0.00%0.0%
Q1 2023$240,296
-29.8%
11,0430.0%0.00%
-33.3%
Q4 2022$342,223
+21.5%
11,0430.0%0.00%
+50.0%
Q3 2022$281,707
+25.7%
11,0430.0%0.00%0.0%
Q2 2022$224,173
-17.9%
11,0430.0%0.00%0.0%
Q1 2022$273,204
+11.8%
11,043
+57.0%
0.00%0.0%
Q4 2021$244,432
+28.1%
7,0340.0%0.00%0.0%
Q3 2021$190,762
-34.7%
7,034
-37.6%
0.00%
-33.3%
Q2 2021$292,257
+20.3%
11,2710.0%0.00%
+50.0%
Q1 2021$242,890
+0.2%
11,2710.0%0.00%0.0%
Q4 2020$242,327
+45.8%
11,2710.0%0.00%0.0%
Q3 2020$166,247
-34.0%
11,2710.0%0.00%
-33.3%
Q2 2020$251,794
+58.1%
11,2710.0%0.00%
+50.0%
Q1 2020$159,259
-13.0%
11,2710.0%0.00%0.0%
Q4 2019$183,154
-53.6%
11,2710.0%0.00%
-60.0%
Q3 2019$394,372
-38.0%
11,2710.0%0.01%
-28.6%
Q2 2019$635,908
-8.2%
11,271
+18.9%
0.01%
-12.5%
Q1 2019$692,660
+14.5%
9,4820.0%0.01%0.0%
Q4 2018$604,857
-26.4%
9,482
+15.1%
0.01%
-11.1%
Q3 2018$822,005
+40.5%
8,2390.0%0.01%
+28.6%
Q2 2018$585,000
-31.8%
8,2390.0%0.01%
-30.0%
Q1 2018$858,000
+3.4%
8,2390.0%0.01%
+11.1%
Q4 2017$830,0008,2390.01%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$81,462,73111.84%
EcoR1 Capital, LLC 7,521,024$233,076,5347.09%
5AM Venture Management, LLC 357,733$11,086,1462.98%
Boxer Capital, LLC 1,300,000$40,287,0002.12%
Frazier Life Sciences Management, L.P. 899,700$27,881,7031.73%
Palo Alto Investors LP 431,024$13,357,4341.14%
Logos Global Management LP 250,000$7,747,5000.91%
BRAIDWELL LP 726,122$22,502,5210.75%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,161,826$36,004,9880.74%
Rock Springs Capital Management LP 576,600$17,868,8340.43%
View complete list of ANAPTYSBIO INC shareholders